Treatment of myelodysplasia-associated reactive, non-interstitial granulomatous dermatitis with hydroxychloroquine

Int J Dermatol. 2023 Jul;62(7):e398-e399. doi: 10.1111/ijd.16441. Epub 2022 Oct 10.

Authors

Rachel Choi¹, Shaman Bhullar¹, Earl Glusac^{1

2}, Nikolai Podoltsev³, Jonathan Leventhal¹

Affiliations

¹ Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
² Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
³ Department of Medicine (Hematology), Yale University School of Medicine, New Haven, CT, USA.

PMID: 36214463
DOI: 10.1111/ijd.16441

No abstract available

Publication types

Letter

MeSH terms

Autoimmune Diseases*
Dermatitis*
Granuloma
Humans
Hydroxychloroquine

Substances

Hydroxychloroquine